Speakers will present the latest research on the use of probiotics to treat a variety of conditions, including cancer, metabolic syndrome, and neurodegenerative diseases.
Topics & Sessions
- Introduction to Probiotics and Microbiota Supplements
- Strain Specificity: Why It Matters
- Probiotics in Cancer Treatment
- Probiotic Strains for Metabolic Syndromes
- Probiotic Strains, Depression and Neurodegenerative Diseases
- Clinical Recommendations: A Guide for Healthcare Providers
Research Companies that employ probiotics in their products and possess clinical data validating their product’s efficacy in treating diseases are invited to share their clinical results, and can contact the International Society of Microbiota to know more.
Upon completion of the symposium, participants should possess a robust understanding of the integration of these supplements into patient care, promoting a tailored and evidence-driven treatment strategy.
“The goal of this symposium is to provide clinicians and healthcare practitioners with the latest information on the use of probiotics and microbiota supplements”, said Prof. Marvin Edeas, founder and chairman of the International Society of Microbiota. “We believe that this symposium will be a valuable resource for anyone who wants to learn more about the clinical significance of these supplements.”
The symposium is open to all healthcare professionals, including doctors, nurses, dietitians, and pharmacists. Registration is now open and can be completed online at www.microbiota-site.com.
The ISM 10th World Congress on Targeting Microbiota runs from October 17th to October 19th, dedicating the first day for the symposium along with microbiota business workshop. On October 18 and 19, Targeting Microbiota 2023 Conference will be held with attendees from more than 35 countries.